TARA generates human relevant data to enable faster, safer, and more accurate development of new treatments. Our platform can reduce cost and increase the success of important new medicines reaching patients.
Cardiac Drug Discovery
We generate disease models from stem cells, enabling discovery of new medicines for heart conditions.
Cardiac Safety
Our cardiac tissue models reliably represent adult human hearts when applied to drug testing. We can accurately identify cardiovascular complications.
Precision Cardiology
Our platform can be used to create custom cardiac models tailored to a single person, allowing for personalized health and treatment.
Tuesday March 3, 2020 – Keystone, Colorado. TARA Biosystems Inc. today reported data showcasing its Biowire™ II as a platform for heart failure drug discovery. Speaking at this year’s
NEW YORK, NY (Newswire.com)—TARA Biosystems, Inc. today reported in vivo and in vitro functional data from a study of investigational candidate, MYK-491, showing that TARA’s human…
READ MORENEW YORK, NY (Newswire.com) - TARA Biosystems, Inc. launched Cardiotype.Ca™, its in vitro system for assessing cardiac calcium signaling. The new assay can be used independently or in combination…
READ MORE
